After seeing a drop in its domestic business in the first quarter of FY21, India’s Alkem Laboratories Ltd has announced growth of 6.3% in Indian sales to INR15.1bn ($207m) in its financial third quarter ended 31 December 2020. For the first nine months of FY21, the company's domestic sales were INR42.3bn compared to INR42.0bn reported in the corresponding prior year period.
Alkem managing director Sandeep Singh commented, “Over the last two quarters, our India business has shown a significant recovery from...







